Bioactive Products
A unique collection of 41 natural compounds used for Anti-diabetic research | ||
Catalog No: | B544 | Anti-diabetic Compound Library Screening Details |
Size: | 1mg/well * 41 Compounds 2mg/well * 41 Compounds |
Cat. No. | Information |
CFN90498 | Cycloart-23-ene-3,25-diol Cycloart-23-ene-3,25-diol has anti-inflammatory activity, it has protective activity against streptozotocin induced toxicity. Cycloart-23-ene-3,25-diol treatment can decrease liver malondialdehyde but increase superoxidase dismutase and reduced glutathione. |
CFN92569 | Alizarin 2-methyl ether Alizarin 2-methyl ether enhances adipocyte differentiation by up to 131%, it could be beneficial in the treatment of diabetes. |
CFN90538 | Gymnemic acid I Gymnemic acid I is a protein biosynthesis inhibitor, it as antisweet principles. |
CFN90550 | L-Arginine L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. L-Arginine exhibits anti-atherosclerotic effect, L-arginine and soy enriched diet are effective in prevention of osteoporosis associated with diabetes mellitus. Exogenous L-Arginine could enhance neonate lymphocyte proliferation through an interleukin-2-independent pathway. |
CFN92665 | 3',5'-Diprenylgenistein 3',5'-Diprenylgenistein inhibits protein tyrosine phosphatase 1B (PTP1B) activities, it can reduce muscle cell viability. 3',5'-Diprenylgenistein exhibits significant glucose-uptake activity in basal and insulin-stimulated L6 myotubes. |